Joachim Yahalom, MD

home / authors / joachim-yahalom-md

Articles

Hodgkin Lymphoma

Dennis A. Eichenauer, MD;Joachim Yahalom, MD;Volker Diehl, MD, PhD

June 1st 2016

This management guide covers the risk factors, screening, diagnosis, staging, and treatment of Hodgkin lymphoma.

Patients With H pylori–Independent MALT Lymphoma Are Curable With Radiotherapy

Joachim Yahalom, MD

November 15th 2011

After more than two decades of successful laboratory and clinical research, the "new" entity of mucosa-associated lymphoid tissue (MALT) lymphoma is reaching a noble maturity.

Cancer Management Chapter 26: Hodgkin lymphoma

Joachim Yahalom, MD;David Straus, MD

March 12th 2010

In 2009 approximately 8,510 new cases of Hodgkin lymphoma (HL) will be diagnosed in the United States. Over the past 4 decades, advances in radiation therapy and the advent of combination chemotherapy have tripled the cure rate of patients with HL. In 2009, more than 80% of all newly diagnosed patients can expect a normal, disease-free life span.

Hodgkin’s lymphoma

Joachim Yahalom, MD;David Straus, MD

January 1st 2005

In the year 2005, approximately 8,000 new cases of Hodgkin's lymphoma (HL)will be diagnosed in the United States. Over the past 4 decades, advances inradiation therapy and the advent of combination chemotherapy have tripledthe cure rate of patients with HL. In 2005, more than 80% of all newly diagnosedpatients can expect a normal, disease-free life span.